From clinical trials to corporate announcements, we're proud to share our recent updates and progress with the community. Scroll below to see what we've been up to, or contact the team for further information. If you are a member of the media, please send your inquiry to firstname.lastname@example.org. If you are an investor, please visit our investor page.
An error has occurred. Please refresh the page and retry.
Keep in Touch
To stay up to date on Amylyx news, click subscribe.